About Mizar Therapeutics
Mizar Therapeutics is a private company based in Woods Hole, Massachusetts, incorporated in 2022 in Delaware. It has reported $518,616 raised in one offering on Form D since June 2025. Its chief executive is Joel Smith.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| May 9, 2025 | Jun 9, 2025 | $518,616of $718K target | 6 | $86,436 | EquityRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Mizar Therapeutics's Form D filed Jun 9, 2025.
PM
Paul Maddox
Executive officer and director
JS
Joel Smith
CEO and director